Author

E. Vidales

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. Tindle· 2 shared K. Perry· 2 shared P. Ghosh· 2 shared S. Taheri· 2 shared A. Adel· 1 shared A. Fonseca· 1 shared A. Ondersma· 1 shared B. Boland· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Tindle

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Machine Learning Guided Differentiation Therapy Targets Cancer Stem Cells in Colorectal Cancers

S. Sinha, J. Alcantara, K. Perry, V. Castillo, A. Ondersma, S. Banerjee, E. McLaren, C. R. Espinoza, S. Taheri, E. Vidales, C. Tindle, A. Adel, S. Amirfakhri, J. R. Sawires, J. Yang, , P. Ghosh

This paper introduces a machine learning framework to identify and target transcriptomic vulnerabilities in colorectal cancer, demonstrating that differentiation therapy selectively eliminates cancer stem cells and reduces recurrence risk.

bioRxiv · Sep 13, 2023 · PreprintCancer Biology

A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics

C. Tindle, G. Katkar, A. Fonseca, S. Taheri, J. Lee, P. Maity, I. Sayed, S.-R. Ibeawuchi, E. Vidales, R. Pranadinata, M. Fuller, D. Stec, M. S. Anandachar, K. Perry, H. Lee, , P. Ghosh

This paper creates a biobank of patient-derived organoids to identify molecular subtypes of Crohn's disease and test subtype-specific therapies.

bioRxiv · Mar 11, 2023Immunology